(Q34179339)

31 July 2017

A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients (English)

1 reference

31 July 2017

C E Garnett

2

0 references

author name string

J Florian

1

1 reference

31 July 2017

S C Nallani

3

1 reference

31 July 2017

B A Rappaport

4

1 reference

31 July 2017

D C Throckmorton

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

29 February 2012

1 reference

Clinical Pharmacology & Therapeutics

31 July 2017

1 reference

31 July 2017

91

1 reference

31 July 2017

4

1 reference

31 July 2017

666-672

1 reference

Oral methadone for managing chronic nonmalignant pain

31 July 2017

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

QTc interval prolongation associated with intravenous methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Torsade de pointes associated with very-high-dose methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Impact of methadone treatment on cardiac repolarization and conduction in opioid users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

QTc interval screening in methadone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Drug-induced prolongation of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

The pharmacokinetics of methadone in healthy subjects and opiate users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Risk stratification in the long-QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Prolonged QTc interval and risk of sudden cardiac death in a population of older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Measurement of QTc in patients receiving chronic methadone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

QTc interval prolongation in patients on long-term methadone maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Medication-assisted treatment and HIV/AIDS: aspects in treating HIV-infected drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Stereoselective Block of hERG Channel by (S)-Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

7 January 2021

Methadone-associated QT prolongation and torsades de pointes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

7 January 2021

Methadone and QT prolongation in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

7 January 2021

High-dose methadone and QTc prolongation: strategies to optimize safety

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

7 January 2021

Methadone and QT prolongation: a dose-dependent effect?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

7 January 2021

Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

7 January 2021

Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

7 January 2021

Probable metabolic interaction between methadone and fluvoxamine in addict patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.273

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.273

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hsuevqdjozhtzosnxtsoggayh4

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_hsuevqdjozhtzosnxtsoggayh4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hsuevqdjozhtzosnxtsoggayh4

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/hsuevqdjozhtzosnxtsoggayh4

30 July 2022